- Acetylsalicylic acid (aspirin)
- Thienopyridines
- Glycoprotein IIb/IIIa receptor inhibitors
Resistance to antiplatelet agents/drug interactions
Withdrawal of antiplatelet agents
It looks simple, but it is huge! huh!
Atorvastatin 20 mg Tablet
Atorvastatin 40 mg Tablet
Atorvastatin 80 mg Tablet
Ezetimibe 10 mg & Simvastatin 20 mg Tablet
Lovastatin 20 mg Tablet
Lovastatin 20 mg Tablet
Rosuvastatin 10 mg Tablet
Rosuvastatin 20 mg Tablet
Simvastatin 10 mg Tablet
Simvastatin 20 mg Tablet
Simvastatin 40 mg Tablet
• Reduce the risk of MI, stroke, revascularization procedures, and angina in patients without CHD, but with multiple risk factors (1.1).
• Reduce the risk of MI and stroke in patients with type 2 diabetes without CHD, but with multiple risk factors (1.1).
• Reduce the risk of non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for CHF, and angina in patients with CHD (1.1).
• Reduce elevated total-C, LDL-C, apo B, and TG levels and increase HDL-C in adult patients with primary hyperlipidemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (1.2).
• Reduce elevated TG in patients with hypertriglyceridemia and primary dysbetalipoproteinemia (1.2).
• Reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH) (1.2).
• Reduce elevated total-C, LDL-C, and apo B levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy (1.2).
A large, randomized, controlled trial has shown that the use of digoxin reduces the rate of hospitalization for heart failure, but does not reduce mortality. - Digitalis Investigation Group: The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336:525-533.q.d. (qd or QD) is once a day; q.d. stands for "quaque die" (which means, in Latin, once a day).
Digoxin is excreted by the kidneys, so dose adjustment is necessary in cases of renal failure.
A low dose of digoxin (0.125 mg daily) should be prescribed to most patients, especially women, and serum digoxin levels maintained at lower than 1 ng/mL. Digoxin may be prescribed for patients with left ventricular systolic dysfunction who remain symptomatic while receiving standard medical therapy, particularly if they are in atrial fibrillation.
Agent : Digoxin
Initial Dose : 0.125 mg qd (A low dose of digoxin (0.125 mg daily) should be prescribed to most patients, especially women)
Maximal Dose : 0.25 mg qd
Loading dose: 0.75-1.5 mg in the 1st 24 hr. Slow digitilisation: 250 mcg 1-2 times/day. Uusal maintenance: 0.125-0.250 mg/day.
IV Emergency heart failure - For patients who have not received cardiac glycosides in the previous 2 wk: 0.5-1 mg via infusion as a single dose or in divided doses
Poison schedule : B
Digoxin 0.25 mg Tablet – Group B
Digoxin 50 mcg/ml Elixir – Group B
Digoxin 500 mcg/2 ml Injection – Group A
Digoxin 62.5 mcg Tablet – Group B
Brand Name : Lanoxin
*1mg = 1000mcg @ 1000µg
http://www.freepatentsonline.com/result.html?query_txt=digoxin&sort=relevance&srch=top&search=
contains all documents related to digixon.
Action & Use - Na /K-ATPase inhibitor; cardiac glycoside.
Storage (for both tablet & solution) - Protected from light.
Identification - Infrared absorption spectrophotometry
Tests for tablet : Dissolution, Uniformity of Content,
For digoxin injection solution (adult preparation),
Digoxin - 25 mg
Ethanol (80 per cent) - 12.5 ml
Propylene Glycol - 40 ml
Citric Acid Monohydrate - 75 mg
Disodium Hydrogen Phosphate Dodecahydrate - 0.45 g
Water for Injections - Sufficient to produce 100 ml
Referring to British National Formulary (BNF), gold can be given by intramuscular injection as sodium aurothiomalate or by mouth as auranofin.
Gold therapy should be discontinued in the presence of blood disorders, gastro-intestinal bleeding (associated with ulcerative enterocolitis), or unexplained proteinuria (associated with immune complex nephritis) which is repeatedly above 300 mg/litre. Urine tests and full blood counts (including total and differential white cell and platelet counts) must therefore be performed before starting treatment with gold and before each intramuscular injection; in the case of oral treatment the urine and blood tests should be carried out monthly. Rashes with pruritus often occur after 2 to 6 months of intramuscular treatment and may necessitate discontinuation of treatment; the most common side-effect of oral therapy, diarrhoea with or without nausea or abdominal pain, may respond to bulking agents (such as bran) or temporary reduction in dosage.Not all people believed that gold can be used as a treatment.